Vitrakvi (Larotrectinib Bottles) 20mg/ml x100ml

Vitrakvi larotrectinib 20mg/ml oral solution treats solid tumors with NTRK gene fusions. This targeted therapy comes in 100ml bottles for precise dosing. Store refrigerated between 2-8°C. Consult a healthcare provider for suitability.

Strength

20mg/ml x100ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Bayer Healthcare

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vitrakvi larotrectinib is used for adults and children with solid tumors that have an NTRK gene fusion. It targets cancer cells specifically, helping to slow or stop tumor growth. This medication is prescribed when the cancer has spread or cannot be removed by surgery. It is not for general pain relief or common infections.

Side Effects

Patients may notice changes in energy levels or appetite while taking Vitrakvi. Some experience digestive effects like nausea or constipation. Hair loss or skin changes can occur as the body adjusts. These effects vary and should be discussed with a healthcare provider if persistent.

Precautions & Warnings

Keep Vitrakvi refrigerated between 2-8°C and protect from light. Avoid exposure to extreme temperatures. Use only as directed by a healthcare professional. Do not share this medication with others. Report any unusual symptoms to your doctor promptly.

Avoid Interactions

Vitrakvi may interact with strong CYP3A inhibitors or inducers, altering its effectiveness. Avoid grapefruit products while taking this medication. Certain supplements or herbal remedies could also interfere. Always inform your doctor about all medications and supplements you are using.

Frequently Asked Questions

Vitrakvi is prescribed for solid tumors in adults and children caused by NTRK gene fusions.

Store the oral solution refrigerated between 2-8°C and protect it from light.

Follow your doctor’s instructions; food may affect absorption but is not universally restricted.

Common effects include fatigue, nausea, constipation, and skin or hair changes.

Yes, it may interact with CYP3A inhibitors or inducers and grapefruit products.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.